CDCA8 expression and its clinical relevance in patients with bladder cancer

Medicine
Yaqiong BiSheng Li

Abstract

Cell division cycle associated 8 (CDCA8) overexpression is detected in various malignant tumors and closely associated with tumor growth. However, the correlations of CDCA8 expression with clinicopathological factors and prognosis of bladder cancer (BC) remain unclear. The purpose of this study was to identify the expression of CDCA8 and its clinical relevance in BC patients.GEO datasets were employed to obtain CDCA8 expression data and its clinical information in BC samples. Real-time PCR (RT-PCR) was performed to detect the expression of CDCA8 in BC and the adjacent normal tissues. Nonpaired t test was used to statistically analyze the difference between the 2 groups. Cox univariable and multivariable analyses of overall survival (OS) and cancer specific survival (CSS) among BC patients were performed. Biological processes or signaling pathways that might mediate the activity of CDCA8 in BC were analyzed.CDCA8 levels were significantly higher in BC (8.870 ± 0.08281 vs 7.472 ± 0.07035, P < .0001). CDCA8 expression was significantly associated with tumor progression (P = .001), T stage (P < .0001), N stage (P = .013), and grade (P < .0001). Higher expression of CDCA8 predicted poor cancer-specific survival (P < .0001, HR = 0.27...Continue Reading

References

Aug 22, 2002·Current Cancer Drug Targets·M G Walker
Nov 19, 2004·Nature·Michael B Kastan, Jiri Bartek
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ju-Seog LeeIn-Sun Chu
Nov 24, 2012·Nature Reviews. Molecular Cell Biology·Mar CarmenaWilliam C Earnshaw
Nov 19, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lujia WangZhong Wu
Feb 5, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Diana UrregoLuis A Pardo
Jan 27, 2015·Biochemical Society Transactions·Sanne HindriksenSusanne M A Lens
Sep 14, 2015·Clinical Genitourinary Cancer·Asmaa SalamaHatem Aboulkassem
Jan 11, 2017·Biochemical and Biophysical Research Communications·Mingyue TanJianxin Qiu
Jan 18, 2017·Genesis : the Journal of Genetics and Development·Georgina A Stooke-VaughanSarah Woolner
Feb 6, 2017·Biochemical and Biophysical Research Communications·Liyun YueLijian Hui

❮ Previous
Next ❯

Citations

Mar 10, 2021·Cancer Cell International·Yu ShuaiGuihai Zhang
May 11, 2021·Pathology, Research and Practice·Chunxiu HuZhongyu Jiang

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE13507

Methods Mentioned

BETA
PCR
PCRs

Software Mentioned

SPSS
GSEA
GraphPad Prism

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.